Albendazole Cospharm Chewable tablet
PDF Leaflet Revision Date: 27 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of intestinal parasites.
Dosage (summary)
Single oral dose for adults and children over 2 years.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not established in breastfeeding.
Key Drug Interactions
- Praziquantel
- Ritonavir
- Phenytoin
- Carbamazepine
- Phenobarbital
Contraindications
- Hypersensitivity to albendazole
- Pregnancy
Common side effects
- Headache
- Dizziness
- Nausea
- Vomiting
- Rash
Counselling Points
- Take with food if needed
- Monitor for neurological symptoms
- Avoid in early pregnancy
Serious warnings
- Teratogenic effects
- Potential for neurocysticercosis symptoms
Important Disclaimer
The Albendazole Cospharm Chewable tablet professional information leaflet below is the property of Cospharm Investments and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
